Phenotypic variability among adult siblings with Sjögren-Larsson syndrome

Archives of Neurology

Volumn 63, Issue 2, 2006, Pages 278-280

  Lossos, Alexander ^a   Khoury, Moona ^b   Rizzo, William B ^c   Gomori, John M ^a   Banin, Eyal ^a   Zlotogorski, Abraham ^a   Jaber, Saleh ^a   Abramsky, Oded ^a   Argov, Zohar ^a   Rosenmann, Hanna ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; IMAGING; MALE; NEUROLOGIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SJOEGREN LARSSON SYNDROME; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGE OF ONSET; ALDEHYDE OXIDOREDUCTASES; BRAIN; CONSANGUINITY; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHENOTYPE; PROGNOSIS; SIBLINGS; SJOGREN-LARSSON SYNDROME;

EID: 32944462854     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.63.2.278     Document Type: Article

References (11)

1. Rizzo WB. Sjögren-Larsson syndrome: fatty aldehyde dehydrogenase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill Co; 2001:2239-2258.
2. Willemsen MA, Ijlst L, Steijlen PM, et al. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome. Brain. 2001;124(pt 7):1426-1437.
3. Willemsen MA, van der Graaf M, van der Knaap MS, et al. MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy. AJNR Am J Neuroradiol. 2004;25:649-657.
4. Rizzo WB. Sjögren-Larsson syndrome. Neurology. 1999;52:1307-1308.
5. Gomori JM, Leibovici V, Zlotogorski A, Wirguin I, Haham-Zadeh S. Computed tomography in Sjögren-Larsson syndrome. Neuroradiology. 1987;29:557-559.
6. Rogers GR, Rizzo WB, Zlotogorski A, et al. Genetic homogeneity in Sjögren-Larsson syndrome. Am J Hum Genet. 1995;57:1123-1129.
7. Rizzo WB, Carney G, Lin Z. The molecular basis of Sjögren-Larsson syndrome. Am J Hum Genet. 1999;65:1547-1560.
8. Lyon G, Adams RD, Kolodny EH, eds. Neurology of Hereditary Metabolic Diseases of Children. 2nd ed. New York, NY: McGraw-Hill Co; 1996.
9. van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. 2nd ed. Berlin, Germany: Springer-Verlag; 1995.
10. Carney G, Wei S, Rizzo WB. Sjögren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2. Hum Mutat. 2004;24:186.
11. Willemsen MA, Lutt MA, Steijlen PM, et al. Clinical and biochemical effects of zileuton in patients with the Sjögren-Larsson syndrome. Eur J Pediatr. 2001;160:711-717.